MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Acetylcholine"

  • 2023 International Congress

    Cholinergic deficits in Parkinson Disease

    R. Miller, D. Dhavale, J. O’Shea, E. Franklin, N. Cairns, R. Perrin, M. Campbell, J. Perlmutter, P. Kotzbauer (St. Louis, USA)

    Objective: To determine whether loss of cholinergic projections to cortical and limbic regions contributes to the development of dementia in Parkinson’s disease (PD). Background: PD…
  • 2023 International Congress

    Cholinergic subtyping in Parkinson disease: differential 2-year interval changes

    N. Bohnen, S. Roytman, T. Brown, K. Frey, P. Scott, R. Koeppe, R. Albin, P. Kanel (Ann Arbor, USA)

    Objective: To investigate 2-yr interval change in cholinergic transporters in biology-based cholinergic subgroups using serial VAChT [18F]FEOBV brain PET in Parkinson’s disease (PD). Background: Current…
  • 2023 International Congress

    Free water imaging of the cholinergic forebrain in body vs. brain-first Parkinson’s disease subtypes

    S. Roytman, Y. Ota, T. Brown, P. Scott, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To investigate the relationship between basal forebrain (BF) neurodegeneration and cholinergic system in body vs brain-first Parkinson’s disease (PD) subtypes. Background: Free water imaging…
  • 2023 International Congress

    The comparison of curcumin and naringenin effects on motor function in rotenone model of Parkinson’s disease

    S. Madiha (Karachi, Pakistan)

    Objective: The aim of the study was to compare the effects of curcumin and naringenin on rotenone-induced motor deficits and related neurochemical changes. Background: Experimental…
  • 2023 International Congress

    The development of a multiplex allele specific PCR to improve the diagnostic yield of NGS in the GBA gene screening

    C. Panteghini, C. Reale, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milano, Italy)

    Objective: Our aim is to offer a complete and reliable diagnostic service excluding false negative. Background: Heterozygous variants in the GBA gene are the most…
  • 2023 International Congress

    Nucleus basalis of Meynert and total gray matter atrophy are related to cognitive and gait decline in Parkinson’s disease

    A. Yeung, F. Ba, M. Gee, R. Camicioli (Edmonton, Canada)

    Objective: To assess the associations between the nucleus basalis of Meynert (NBM) and total grey matter atrophy with cognitive phenotype and gait measures in a…
  • 2023 International Congress

    Hesperidin ameliorates rotenone-induced Parkinson’s disease in mice via improving neuroinflammation and oxidative stress

    D. Singh (Prayagraj, India)

    Objective: The goal of the present study is to examine the neuroprotective property of hesperidin on rotenone-induced Parkinson's disease in mice. Background: The second most…
  • 2023 International Congress

    Cholinergic topography and clinical profile of early Parkinson’s patients with GBA mutations

    S. Slingerland, S. Vander Zee, G. Carli, A. Slomp, J. Boertien, T. van Laar (Groningen, Netherlands)

    Objective: To explore the regional cholinergic innervation and clinical profile of early Parkinson’s disease (PD) patients carrying GBA mutations (GBA-PD). Background: The most common genetic…
  • 2023 International Congress

    Topography of cholinergic vulnerability correlates of PIGD motor deficits in DLB and PSP: A [18F]-FEOBV PET study

    P. Kanel, T. Brown, S. Roytman, J. Barr, C C. Spears, N. Bohnen (Ann Arbor, USA)

    Objective: To understand the relationship between cholinergic vulnerability and Postural Instability and Gait Disturbances (PIGD) motor features in dementia with Lewy bodies (DLB), and progressive…
  • 2022 International Congress

    Muscarinic M2 cholinergic receptors in cervical dystonia

    P. Kassavetis, M. Hosseini, K. Mente, R. Waugh, E. Shamim, W. Dieckmann, P. Herscovitch, M. Hallett, S. Horovitz (Salt Lake City, USA)

    Objective: To characterize the M2 muscarinic acetylcholine receptor binding in patients with cervical dystonia, measured with non-invasive high-resolution PET, using [18F]FP-TZTP ligand. Background: While antimuscarinic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley